112 related articles for article (PubMed ID: 20426785)
1. Imiquimod simultaneously induces autophagy and apoptosis in human basal cell carcinoma cells.
Huang SW; Liu KT; Chang CC; Chen YJ; Wu CY; Tsai JJ; Lu WC; Wang YT; Liu CM; Shieh JJ
Br J Dermatol; 2010 Aug; 163(2):310-20. PubMed ID: 20426785
[TBL] [Abstract][Full Text] [Related]
2. Imiquimod activates p53-dependent apoptosis in a human basal cell carcinoma cell line.
Huang SW; Chang SH; Mu SW; Jiang HY; Wang ST; Kao JK; Huang JL; Wu CY; Chen YJ; Shieh JJ
J Dermatol Sci; 2016 Mar; 81(3):182-91. PubMed ID: 26775629
[TBL] [Abstract][Full Text] [Related]
3. Mcl-1 determines the imiquimod-induced apoptosis but not imiquimod-induced autophagy in skin cancer cells.
Huang SW; Chang CC; Lin CC; Tsai JJ; Chen YJ; Wu CY; Liu KT; Shieh JJ
J Dermatol Sci; 2012 Mar; 65(3):170-8. PubMed ID: 22305615
[TBL] [Abstract][Full Text] [Related]
4. Imiquimod-induced AMPK activation causes translation attenuation and apoptosis but not autophagy.
Wang ST; Huang SW; Kao JK; Liang SM; Chen YJ; Chen YY; Wu CY; Shieh JJ
J Dermatol Sci; 2015 May; 78(2):108-16. PubMed ID: 25766763
[TBL] [Abstract][Full Text] [Related]
5. Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod.
Schön M; Bong AB; Drewniok C; Herz J; Geilen CC; Reifenberger J; Benninghoff B; Slade HB; Gollnick H; Schön MP
J Natl Cancer Inst; 2003 Aug; 95(15):1138-49. PubMed ID: 12902443
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis.
Vidal D; Matías-Guiu X; Alomar A
Br J Dermatol; 2004 Sep; 151(3):656-62. PubMed ID: 15377354
[TBL] [Abstract][Full Text] [Related]
7. In vivo characterization of the inflammatory infiltrate and apoptotic status in imiquimod-treated basal cell carcinoma.
De Giorgi V; Salvini C; Chiarugi A; Paglierani M; Maio V; Nicoletti P; Santucci M; Carli P; Massi D
Int J Dermatol; 2009 Mar; 48(3):312-21. PubMed ID: 19261026
[TBL] [Abstract][Full Text] [Related]
8. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.
Vidal D; Matías-Guiu X; Alomar A
Clin Exp Dermatol; 2004 Sep; 29(5):518-25. PubMed ID: 15347339
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of superficial basal cell carcinomas after treatment with imiquimod 5% cream or vehicle for apoptosis and lymphocyte phenotyping.
Sullivan TP; Dearaujo T; Vincek V; Berman B
Dermatol Surg; 2003 Dec; 29(12):1181-6. PubMed ID: 14725659
[TBL] [Abstract][Full Text] [Related]
10. Imiquimod treatment induces expression of opioid growth factor receptor: a novel tumor antigen induced by interferon-alpha?
Urosevic M; Oberholzer PA; Maier T; Hafner J; Laine E; Slade H; Benninghoff B; Burg G; Dummer R
Clin Cancer Res; 2004 Aug; 10(15):4959-70. PubMed ID: 15297396
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 7 agonist, imiquimod, inhibits oral squamous carcinoma cells through apoptosis and necrosis.
Ahn MY; Kwon SM; Cheong HH; Park JH; Lee J; Min SK; Ahn SG; Yoon JH
J Oral Pathol Med; 2012 Aug; 41(7):540-6. PubMed ID: 22577802
[TBL] [Abstract][Full Text] [Related]
12. Imiquimod in basal cell carcinoma: how does it work?
Dummer R; Urosevic M; Kempf W; Hoek K; Hafner J; Burg G
Br J Dermatol; 2003 Nov; 149 Suppl 66():57-8. PubMed ID: 14616353
[TBL] [Abstract][Full Text] [Related]
13. Immune modulation and apoptosis induction: two sides of the antitumoral activity of imiquimod.
Schön MP; Schön M
Apoptosis; 2004 May; 9(3):291-8. PubMed ID: 15258460
[TBL] [Abstract][Full Text] [Related]
14. Effect of imiquimod as compared with surgery on the cancerization field in basal cell carcinoma.
Graells J; Ojeda RM; García-Cruz A
Actas Dermosifiliogr; 2014; 105(1):53-9. PubMed ID: 24139468
[TBL] [Abstract][Full Text] [Related]
15. Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle.
Berman B; Sullivan T; De Araujo T; Nadji M
Br J Dermatol; 2003 Nov; 149 Suppl 66():59-61. PubMed ID: 14616354
[TBL] [Abstract][Full Text] [Related]
16. Imiquimod inhibits the growth of SGC‑7901 cells in vitro through induction of autophagy and apoptosis.
Jiang J; Dong L; Shi HT; Guo XY; Qin B; Wang Y; Li H
Mol Med Rep; 2016 Jan; 13(1):393-7. PubMed ID: 26549648
[TBL] [Abstract][Full Text] [Related]
17. Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod.
Schön MP; Wienrich BG; Drewniok C; Bong AB; Eberle J; Geilen CC; Gollnick H; Schön M
J Invest Dermatol; 2004 May; 122(5):1266-76. PubMed ID: 15140231
[TBL] [Abstract][Full Text] [Related]
18. Arecoline decreases interleukin-6 production and induces apoptosis and cell cycle arrest in human basal cell carcinoma cells.
Huang LW; Hsieh BS; Cheng HL; Hu YC; Chang WT; Chang KL
Toxicol Appl Pharmacol; 2012 Jan; 258(2):199-207. PubMed ID: 22108589
[TBL] [Abstract][Full Text] [Related]
19. Imiquimod 5% cream (Aldara) in the treatment of basal cell carcinoma.
Sapijaszko MJ
Skin Therapy Lett; 2005; 10(6):2-5. PubMed ID: 16292452
[TBL] [Abstract][Full Text] [Related]
20. Imiquimod induced regression of clinically diagnosed superficial basal cell carcinoma is associated with early infiltration by CD4 T cells and dendritic cells.
Barnetson RS; Satchell A; Zhuang L; Slade HB; Halliday GM
Clin Exp Dermatol; 2004 Nov; 29(6):639-43. PubMed ID: 15550144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
